We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
STOR
STORE Capital Corporation
STOR
+$172M
3
FHN icon
First Horizon
FHN
+$107M
4
COUP
Coupa Software Incorporated
COUP
+$96.9M
5
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$64.6M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
AVLR
Avalara, Inc.
AVLR
+$373M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M
5
ROG icon
Rogers Corp
ROG
+$219M

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RAIN icon
351
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$2.41M 0.04%
300,956
-25,495
-8% -$160K
2022 Q1
3 quarters
FATP
352
DELISTED
Fat Projects Acquisition Corp Class A Ordinary Share
FATP
$2.4M 0.04%
236,311
-2,312
-1% -$23.2K
2021 Q4
4 quarters
TCVA
353
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
$2.39M 0.04%
236,972
-2,319
-1% -$23K
2021 Q2
6 quarters
INTE icon
354
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
$2.39M 0.04%
236,311
-2,312
-1% -$23.2K
2022 Q2
2 quarters
MVLA
355
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$2.39M 0.04%
237,190
-2,329
-1% -$23.2K
2021 Q2
6 quarters
ENER
356
DELISTED
Accretion Acquisition Corp
ENER
$2.39M 0.04%
236,311
-2,312
-1% -$23.1K
2021 Q4
4 quarters
CRZN
357
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
$2.39M 0.04%
236,311
-2,312
-1% -$23.1K
2021 Q2
6 quarters
IVCB icon
358
DELISTED
Investcorp Europe Acquisition Corp I Class A Ordinary Shares
IVCB
$2.39M 0.04%
231,686
-2,267
-1% -$23.1K
2022 Q1
3 quarters
EVE icon
359
DELISTED
EVe Mobility Acquisition Corp
EVE
$2.39M 0.04%
231,686
-2,267
-1% -$23K
2022 Q2
2 quarters
ELIQ
360
DELISTED
Electriq Power Holdings, Inc.
ELIQ
$2.39M 0.04%
234,376
-2,303
-1% -$23.1K
2021 Q1
7 quarters
RDZN icon
361
Roadzen
RDZN
$95.4M
$2.38M 0.04%
231,686
-2,267
-1% -$23K
2022 Q1
3 quarters
CHAA icon
362
DELISTED
Catcha Investment Corp
CHAA
$2.38M 0.04%
236,311
-2,312
-1% -$23.1K
2021 Q2
6 quarters
TWOA
363
DELISTED
two
TWOA
$2.38M 0.04%
236,311
-2,312
-1% -$23.1K
2021 Q2
6 quarters
VEEA
364
Veea Inc
VEEA
$15.1M
$2.38M 0.04%
11,816
-115
-1% -$23K
2021 Q2
6 quarters
ITAQ
365
DELISTED
Industrial Tech Acquisitions II, Inc. Class A Common Stock
ITAQ
$2.38M 0.04%
233,953
– –
2022 Q1
3 quarters
TLGY icon
366
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
$2.38M 0.04%
231,686
-2,267
-1% -$23K
2022 Q1
3 quarters
PEGR icon
367
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$2.38M 0.04%
236,311
-2,312
-1% -$23K
2022 Q1
3 quarters
DNAB
368
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$2.38M 0.04%
236,311
-2,312
-1% -$23K
2021 Q2
6 quarters
JCIC
369
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
$2.38M 0.04%
234,934
-2,309
-1% -$23.1K
2021 Q1
7 quarters
BFAC icon
370
DELISTED
Battery Future Acquisition Corp.
BFAC
$2.38M 0.04%
231,686
-2,267
-1% -$23K
2022 Q2
2 quarters
PTOC
371
DELISTED
Pine Technology Acquisition Corp. Class A Common Stock
PTOC
$2.38M 0.04%
235,542
-2,305
-1% -$22.9K
2021 Q2
6 quarters
PRLH icon
372
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
$2.38M 0.04%
231,686
-2,267
-1% -$22.9K
2022 Q2
2 quarters
BCYC icon
373
Bicycle Therapeutics
BCYC
$265M
$2.38M 0.04%
80,304
+12,679
+19% +$340K
2022 Q1
3 quarters
SEDA icon
374
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$2.38M 0.04%
236,311
-2,312
-1% -$23.1K
2022 Q1
3 quarters
FICV
375
DELISTED
Frontier Investment Corp Class A Ordinary Shares
FICV
$2.38M 0.04%
236,311
-2,312
-1% -$22.9K
2021 Q3
5 quarters
13 14
15
16 17

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.